Deregulated microRNAs identified in isolated glioblastoma stem cells: An overview

Cell Transplantation

Volumn 22, Issue 4, 2013, Pages 741-753

  Chu, Pei Ming ^a,b   Ma, Hsin I ^c   Chen, Li Hsin ^d   Chen, Ming Teh ^d,e   Huang, Pin I ^d,e   Lin, Shinn Zong ^b   Chiou, Shih Hwa ^d,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

GBM stem cells (GBMSCs); Glioblastoma; MicroRNA (miRNA); Therapeutic strategy

Indexed keywords

ABC TRANSPORTER; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; ALPHA6 INTEGRIN; BREAST CANCER RESISTANCE PROTEIN; CALMODULIN BINDING PROTEIN; CALMODULIN BINDING TRANSCRIPTION ACTIVATOR 1; CD133 ANTIGEN; CELL ADHESION MOLECULE; L1 CELL ADHESION MOLECULE; MEMBRANE ANTIGEN; MICRORNA; MICRORNA 124; MICRORNA 137; MICRORNA 184; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 26A; MICRORNA 7; MULTIDRUG RESISTANCE PROTEIN 1; NESTIN; NEURAL CELL SURFACE ANTIGEN; STAGE SPECIFIC EMBRYO ANTIGEN 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; AUTOFLUORESCENCE; CANCER CELL CULTURE; CANCER STEM CELL; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL RENEWAL; DNA DAMAGE CHECKPOINT; ENZYME ACTIVITY; GLIOBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; SIDE POPULATION CELL; TUMOR CELL; TUMOROSPHERES;

BRAIN NEOPLASMS; CELL SEPARATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MICRORNAS; NEOPLASTIC STEM CELLS;

EID: 84876473092     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X655190     Document Type: Article

References (126)

1. Al-Hajj, M.; Wicha, M. S.; Benito-Hernandez, A.; Morrison, S. J.; Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100(7):3983-3988; 2003.
2. Allendoerfer, K. L.; Durairaj, A.; Matthews, G. A.; Patterson, P. H. Morphological domains of Lewis-X/ FORSE-1 immunolabeling in the embryonic neural tube are due to developmental regulation of cell surface carbohydrate expression. Dev. Biol. 211(2):208-219; 1999.
3. Bao, S.; Wu, Q.; Li, Z.; Sathornsumetee, S.; Wang, H.; McLendon, R. E.; Hjelmeland, A. B.; Rich, J. N. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res. 68(15):6043-6048; 2008.
4. Bao, S.; Wu, Q.; McLendon, R. E.; Hao, Y.; Shi, Q.; Hjelmeland, A. B.; Dewhirst, M. W.; Bigner, D. D.; Rich, J. N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120):756-760; 2006.
5. Barraud, P.; Stott, S.; Mollgard, K.; Parmar, M.; Bjorklund, A. In vitro characterization of a human neural progenitor cell coexpressing SSEA4 and CD133. J. Neurosci. Res. 85(2):250-259; 2007.
6. Barrett, L. E.; Granot, Z.; Coker, C.; Iavarone, A.; Hambardzumyan, D.; Holland, E. C.; Nam, H. S.; Benezra, R. Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma. Cancer Cell 21(1):11-24; 2012.
7. Bass, A. J.; Watanabe, H.; Mermel, C. H.; Yu, S.; Perner, S.; Verhaak, R. G.; Kim, S. Y.; Wardwell, L.; Tamayo, P.; Gat-Viks, I.; Ramos, A. H.; Woo, M. S.; Weir, B. A.; Getz, G.; Beroukhim, R.; O'Kelly, M.; Dutt, A.; Rozenblatt- Rosen, O.; Dziunycz, P.; Komisarof, J.; Chirieac, L. R.; Lafargue, C. J.; Scheble, V.; Wilbertz, T.; Ma, C.; Rao, S.; Nakagawa, H.; Stairs, D. B.; Lin, L.; Giordano, T. J.; Wagner, P.; Minna, J. D.; Gazdar, A. F.; Zhu, C. Q.; Brose, M. S.; Cecconello, I.; Ribeiro, Jr., U.; Marie, S. K.; Dahl, O.; Shivdasani, R. A.; Tsao, M. S.; Rubin, M. A.; Wong, K. K.; Regev, A.; Hahn, W. C.; Beer, D. G.; Rustgi, A. K.; Meyerson, M. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat. Genet. 41(11):1238-1242; 2009.
8. Beatus, P.; Lendahl, U. Notch and neurogenesis. J. Neurosci. Res. 54(2):125-136; 1998.
9. Beier, D.; Hau, P.; Proescholdt, M.; Lohmeier, A.; Wischhusen, J.; Oefner, P. J.; Aigner, L.; Brawanski, A.; Bogdahn, U.; Beier, C. P. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 67(9):4010-4015; 2007.
10. Bhat-Nakshatri, P.; Appaiah, H.; Ballas, C.; Pick-Franke, P.; Goulet, Jr., R.; Badve, S.; Srour, E. F.; Nakshatri, H. SLUG/ SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype. BMC Cancer 10:411; 2010.
11. Blazek, E. R.; Foutch, J. L.; Maki, G. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 67(1):1-5; 2007.
12. Bleau, A. M.; Hambardzumyan, D.; Ozawa, T.; Fomchenko, E. I.; Huse, J. T.; Brennan, C. W.; Holland, E. C. PTEN/ PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4(3):226-235; 2009.
13. Bonnet, D.; Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3(7):730-737; 1997.
14. Broadley, K. W.; Hunn, M. K.; Farrand, K. J.; Price, K. M.; Grasso, C.; Miller, R. J.; Hermans, I. F.; McConnell, M. J. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme. Stem Cells 29(3):452-461; 2011.
15. Chaichana, K.; Zamora-Berridi, G.; Camara-Quintana, J.; Quinones-Hinojosa, A. Neurosphere assays: Growth factors and hormone differences in tumor and nontumor studies. Stem Cells 24(12):2851-2857; 2006.
16. Challen, G. A.; Little, M. H. A side order of stem cells: The SP phenotype. Stem Cells 24(1):3-12; 2006.
17. Chan, J. A.; Krichevsky, A. M.; Kosik, K. S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65(14):6029-6033; 2005.
18. Chen, Y. C.; Hsu, H. S.; Chen, Y. W.; Tsai, T. H.; How, C. K.; Wang, C. Y.; Hung, S. C.; Chang, Y. L.; Tsai, M. L.; Lee, Y. Y.; Ku, H. H.; Chiou, S. H. Oct-4 expression maintained cancer stem-like properties in lung cancerderived CD133-positive cells. PLoS One 3(7):e2637; 2008.
19. Cheng, L.; Wu, Q.; Huang, Z.; Guryanova, O. A.; Huang, Q.; Shou, W.; Rich, J. N.; Bao, S. L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1. EMBO J. 30(5):800-813; 2011.
20. Chua, C.; Zaiden, N.; Chong, K. H.; See, S. J.; Wong, M. C.; Ang, B. T.; Tang, C. Characterization of a side population of astrocytoma cells in response to temozolomide. J. Neurosurg. 109(5):856-866; 2008.
21. Chute, J. P.; Muramoto, G. G.; Whitesides, J.; Colvin, M.; Safi, R.; Chao, N. J.; McDonnell, D. P. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 103(31):11707-11712; 2006.
22. Clement, V.; Marino, D.; Cudalbu, C.; Hamou, M. F.; Mlynarik, V.; de Tribolet, N.; Dietrich, P. Y.; Gruetter, R.; Hegi, M. E.; Radovanovic, I. Marker-independent identification of glioma-initiating cells. Nat. Methods 7(3):224-228; 2010.
23. Colin, C.; Baeza, N.; Tong, S.; Bouvier, C.; Quilichini, B.; Durbec, P.; Figarella-Branger D. In vitro identification and functional characterization of glial precursor cells in human gliomas. Neuropathol. Appl. Neurobiol. 32(2):189-202; 2006.
24. Corsini, N. S.; Martin-Villalba, A. Integrin a6: Anchors away for glioma stem cells. Cell Stem Cell 6(5):403-404; 2010.
25. Corti, S.; Locatelli, F.; Papadimitriou, D.; Donadoni, C.; Salani, S.; Del Bo, R.; Strazzer, S.; Bresolin, N.; Comi, G. P. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 24(4):975-985; 2006.
26. Delamarre, E.; Taboubi, S.; Mathieu, S.; Berenguer, C.; Rigot, V.; Lissitzky, J. C.; Figarella-Branger, D.; Ouafik, L.; Luis, J. Expression of integrin a6b1 enhances tumorigenesis in glioma cells. Am. J. Pathol. 175(2):844-855; 2009.
27. Denysenko, T.; Gennero, L.; Roos, M. A.; Melcarne, A.; Juenemann, C.; Faccani, G.; Morra, I.; Cavallo, G.; Reguzzi, S.; Pescarmona, G.; Ponzetto, A. Glioblastoma cancer stem cells: Heterogeneity, microenvironment and related therapeutic strategies. Cell Biochem. Funct. 28(5):343-351; 2010.
28. Dirks, P. B. Brain tumor stem cells: Bringing order to the chaos of brain cancer. J. Clin. Oncol. 26(17):2916-2924; 2008.
29. Gal, H.; Pandi, G.; Kanner, A. A.; Ram, Z.; Lithwick- Yanai, G.; Amariglio, N.; Rechavi, G.; Givol, D. MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. Biochem. Biophys. Res. Commun. 376(1):86-90; 2008.
30. Galli, R.; Binda, E.; Orfanelli, U.; Cipelletti, B.; Gritti, A.; De Vitis, S.; Fiocco, R.; Foroni, C.; Dimeco, F.; Vescovi, A. Isolation and characterization of tumorigenic, stemlike neural precursors from human glioblastoma. Cancer Res. 64(19):7011-7021; 2004.
31. Ghods, A. J.; Irvin, D.; Liu, G.; Yuan, X.; Abdulkadir, I. R.; Tunici, P.; Konda, B.; Wachsmann-Hogiu, S.; Black, K. L.; Yu, J. S. Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 25(7):1645-1653; 2007.
32. Gilbert, C. A.; Ross, A. H. Cancer stem cells: Cell culture, markers, and targets for new therapies. J. Cell. Biochem. 108(5):1031-1038; 2009.
33. Gingras, M. C.; Roussel, E.; Bruner, J. M.; Branch, C. D.; Moser, R. P. Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissue. J. Neuroimmunol. 57(1-2):143-153; 1995.
34. Godlewski, J.; Nowicki, M. O.; Bronisz, A.; Williams, S.; Otsuki, A.; Nuovo, G.; Raychaudhury, A.; Newton, H. B.; Chiocca, E. A.; Lawler, S. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 68(22):9125-9130; 2008.
35. Griguer, C. E.; Oliva, C. R.; Gobin, E.; Marcorelles, P.; Benos, D. J.; Lancaster, Jr., J. R.; Gillespie, G. Y. CD133 is a marker of bioenergetic stress in human glioma. PLoS One 3(11):e3655; 2008.
36. Guessous, F.; Zhang, Y.; Kofman, A.; Catania, A.; Li, Y.; Schiff, D.; Purow, B.; Abounader, R. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle 9(6):1031-1036; 2010.
37. Gunther, H. S.; Schmidt, N. O.; Phillips, H. S.; Kemming, D.; Kharbanda, S.; Soriano, R.; Modrusan, Z.; Meissner, H.; Westphal, M.; Lamszus, K. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 27(20):2897-2909; 2008.
38. Hall, P. E.; Lathia, J. D.; Miller, N. G.; Caldwell, M. A.; ffrench-Constant, C. Integrins are markers of human neural stem cells. Stem Cells 24(9):2078-2084; 2006.
39. Haraguchi, N.; Utsunomiya, T.; Inoue, H.; Tanaka, F.; Mimori, K.; Barnard, G. F.; Mori, M. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24(3):506-513; 2006.
40. Harris, M. A.; Yang, H.; Low, B. E.; Mukherjee, J.; Guha, A.; Bronson, R. T.; Shultz, L. D.; Israel, M. A.; Yun, K. Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res. 68(24):10051-10059; 2008.
41. Hemmati, H. D.; Nakano, I.; Lazareff, J. A.; Masterman-Smith, M.; Geschwind, D. H.; Bronner-Fraser, M.; Kornblum, H. I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA 100(25):15178-15183; 2003.
42. Hess, D. A.; Wirthlin, L.; Craft, T. P.; Herrbrich, P. E.; Hohm, S. A.; Lahey, R.; Eades, W. C.; Creer, M. H.; Nolta, J. A. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 107(5):2162-2169; 2006.
43. Hu, Y. Y.; Zheng, M. H.; Cheng, G.; Li, L.; Liang, L.; Gao, F.; Wei, Y. N.; Fu, L. A.; Han, H. Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells. BMC Cancer 11:82; 2011.
44. Huang, E. H.; Hynes, M. J.; Zhang, T.; Ginestier, C.; Dontu, G.; Appelman, H.; Fields, J. Z.; Wicha, M. S.; Boman, B. M. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 69(8):3382-3389; 2009.
45. Huse, J. T.; Brennan, C.; Hambardzumyan, D.; Wee, B.; Pena, J.; Rouhanifard, S. H.; Sohn-Lee, C.; le Sage, C.; Agami, R.; Tuschl, T.; Holland, E. C. The PTENregulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 23(11):1327-1337; 2009.
46. Ignatova, T. N.; Kukekov, V. G.; Laywell, E. D.; Suslov, O. N.; Vrionis, F. D.; Steindler, D. A. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39(3):193-206; 2002.
47. Jeon, H. M.; Sohn, Y. W.; Oh, S. Y.; Kim, S. H.; Beck, S.; Kim, S.; Kim, H. ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*- mediated suppression of SOX2. Cancer Res. 71(9):3410-3421; 2011.
48. Jiang, F.; Qiu, Q.; Khanna, A.; Todd, N. W.; Deepak, J.; Xing, L.; Wang, H.; Liu, Z.; Su, Y.; Stass, S. A.; Katz, R. L. Aldehyde dehydrogenase 1 is a tumor stem cellassociated marker in lung cancer. Mol. Cancer Res. 7(3):330-338; 2009.
49. Jin, Y.; Bin, Z. Q.; Qiang, H.; Liang, C.; Hua, C.; Jun, D.; Dong, W. A.; Qing, L. ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma. J. Cancer Res. Clin. Oncol. 135(10):1369-1376; 2009.
50. Joo, K. M.; Kim, S. Y.; Jin, X.; Song, S. Y.; Kong, D. S.; Lee, J. I.; Jeon, J. W.; Kim, M. H.; Kang, B. G.; Jung, Y.; Jin, J.; Hong, S. C.; Park, W. Y.; Lee, D. S.; Kim, H.; Nam, D. H. Clinical and biological implications of CD133- positive and CD133-negative cells in glioblastomas. Lab. Invest. 88(8):808-815; 2008.
51. Kanamori, M.; Kawaguchi, T.; Nigro, J. M.; Feuerstein, B. G.; Berger, M. S.; Miele, L.; Pieper, R. O. Contribution of Notch signaling activation to human glioblastoma multiforme. J. Neurosurg. 106(3):417-427; 2007.
52. Kefas, B.; Comeau, L.; Floyd, D. H.; Seleverstov, O.; Godlewski, J.; Schmittgen, T.; Jiang, J.; diPierro, C. G.; Li, Y.; Chiocca, E. A.; Lee, J.; Fine, H.; Abounader, R.; Lawler, S.; Purow, B. The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. J. Neurosci. 29(48):15161-15168; 2009.
53. Kefas, B.; Godlewski, J.; Comeau, L.; Li, Y.; Abounader, R.; Hawkinson, M.; Lee, J.; Fine, H.; Chiocca, E. A.; Lawler, S.; Purow, B. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is downregulated in glioblastoma. Cancer Res. 68(10):3566-3572; 2008.
54. Knott, J. C.; Pilkington, G. J. A2B5 surface ganglioside binding distinguishes between two GFAP-positive clones from a human glioma-derived cell line. Neurosci. Lett. 118(1):52-56; 1990.
55. Kondo, T.; Setoguchi, T.; Taga, T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. USA 101(3):781-786; 2004.
56. Lapidot, T.; Sirard, C.; Vormoor, J.; Murdoch, B.; Hoang, T.; Caceres-Cortes, J.; Minden, M.; Paterson, B.; Caligiuri, M. A.; Dick, J. E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367(6464):645-648; 1994.
57. Lathia, J. D.; Gallagher, J.; Heddleston, J. M.; Wang, J.; Eyler, C. E.; Macswords, J.; Wu, Q.; Vasanji, A.; McLendon, R. E.; Hjelmeland, A. B.; Rich, J. N. Integrin a6 regulates glioblastoma stem cells. Cell Stem Cell 6(5):421-432; 2010.
58. Lee, J.; Kotliarova, S.; Kotliarov, Y.; Li, A.; Su, Q.; Donin, N. M.; Pastorino, S.; Purow, B. W.; Christopher, N.; Zhang, W.; Park, J. K.; Fine, H. A. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9(5):391-403; 2006.
59. Lendahl, U.; Zimmerman, L. B.; McKay, R. D. CNS stem cells express a new class of intermediate filament protein. Cell 60(4):585-595; 1990.
60. Li, T.; Li, D.; Sha, J.; Sun, P.; Huang, Y. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem. Biophys. Res. Commun. 383(3):280-285; 2009.
61. Li, W. B.; Ma, M. W.; Dong, L. J.; Wang, F.; Chen, L. X.; Li, X. R. MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme. Cancer Biol. Ther. 12(6):477-483; 2011.
62. Liu, G.; Yuan, X.; Zeng, Z.; Tunici, P.; Ng, H.; Abdulkadir, I. R.; Lu, L.; Irvin, D.; Black, K. L.; Yu, J. S. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer 5:67; 2006.
63. Lottaz, C.; Beier, D.; Meyer, K.; Kumar, P.; Hermann, A.; Schwarz, J.; Junker, M.; Oefner, P. J.; Bogdahn, U.; Wischhusen, J.; Spang, R.; Storch, A.; Beier, C. P. Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer Res. 70(5):2030-2040; 2010.
64. Malzkorn, B.; Wolter, M.; Liesenberg, F.; Grzendowski, M.; Stuhler, K.; Meyer, H. E.; Reifenberger, G. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol. 20(3):539-550; 2010.
65. Maness, P. F.; Schachner, M. Neural recognition molecules of the immunoglobulin superfamily: Signaling transducers of axon guidance and neuronal migration. Nat. Neurosci. 10(1):19-26; 2007.
66. Mao, X. G.; Zhang, X.; Xue, X. Y.; Guo, G.; Wang, P.; Zhang, W.; Fei, Z.; Zhen, H. N.; You, S. W.; Yang, H. Brain tumor stem-like cells identified by neural stem cell marker CD15. Transl. Oncol. 2(4):247-257; 2009.
67. Mei, J.; Bachoo, R.; Zhang, C. L. MicroRNA-146a inhibits glioma development by targeting Notch1. Mol. Cell. Biol. 31(17):3584-3592; 2011.
68. Nan, Y.; Han, L.; Zhang, A.; Wang, G.; Jia, Z.; Yang, Y.; Yue, X.; Pu, P.; Zhong, Y.; Kang, C. MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res. 1359:14-21; 2010.
69. Nishide, K.; Nakatani, Y.; Kiyonari, H.; Kondo, T. Glioblastoma formation from cell population depleted of Prominin1-expressing cells. PLoS One 4(8):e6869; 2009.
70. O'Brien, C. A.; Pollett, A.; Gallinger, S.; Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123):106-110; 2007.
71. Ogden, A. T.; Waziri, A. E.; Lochhead, R. A.; Fusco, D.; Lopez, K.; Ellis, J. A.; Kang, J.; Assanah, M.; McKhann, G. M.; Sisti, M. B.; McCormick, P. C.; Canoll, P.; Bruce, J. N. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery 62(2):505-514; 2008.
72. Papagiannakopoulos, T.; Friedmann-Morvinski, D.; Neveu, P.; Dugas, J. C.; Gill, R. M.; Huillard, E.; Liu, C.; Zong, H.; Rowitch, D. H.; Barres, B. A.; Verma, I. M.; Kosik, K. S. Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene 31(15):1884-1895; 2012.
73. Papagiannakopoulos, T.; Shapiro, A.; Kosik, K. S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 68(19):8164-8172; 2008.
74. - cancer cells are similarly tumorigenic. Cancer Res. 65(14):6207-6219; 2005.
75. Patru, C.; Romao, L.; Varlet, P.; Coulombel, L.; Raponi, E.; Cadusseau, J.; Renault-Mihara, F.; Thirant, C.; Leonard, N.; Berhneim, A.; Mihalescu-Maingot, M.; Haiech, J.; Bieche, I.; Moura-Neto, V.; Daumas-Duport, C.; Junier, M. P.; Chneiweiss, H. CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors. BMC Cancer 10:66; 2010.
76. Pollard, S. M.; Yoshikawa, K.; Clarke, I. D.; Danovi, D.; Stricker, S.; Russell, R.; Bayani, J.; Head, R.; Lee, M.; Bernstein, M.; Squire, J. A.; Smith, A.; Dirks, P. Glioma stem cell lines expanded in adherent culture have tumorspecific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4(6):568-580; 2009.
77. Prince, M. E.; Sivanandan, R.; Kaczorowski, A.; Wolf, G. T.; Kaplan, M. J.; Dalerba, P.; Weissman, I. L.; Clarke, M. F.; Ailles, L. E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 104(3):973-978; 2007.
78. Pruszak, J.; Sonntag, K. C.; Aung, M. H.; Sanchez-Pernaute, R.; Isacson, O. Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations. Stem Cells 25(9):2257-2268; 2007.
79. Purow, B. W.; Haque, R. M.; Noel, M. W.; Su, Q.; Burdick, M. J.; Lee, J.; Sundaresan, T.; Pastorino, S.; Park, J. K.; Mikolaenko, I.; Maric, D.; Eberhart, C. G.; Fine, H. A. Expression of Notch-1 and its ligands, d-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res. 65(6):2353-2363; 2005.
80. Qiang, L.; Yang, Y.; Ma, Y. J.; Chen, F. H.; Zhang, L. B.; Liu, W.; Qi, Q.; Lu, N.; Tao, L.; Wang, X. T.; You, Q. D.; Guo, Q. L. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer Lett. 279(1):13-21; 2009.
81. Rasper, M.; Schafer, A.; Piontek, G.; Teufel, J.; Brockhoff, G.; Ringel, F.; Heindl, S.; Zimmer, C.; Schlegel, J. Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neuro Oncol 12(10):1024-1033; 2010.
82. Raveh, S.; Gavert, N.; Ben-Ze'ev, A. L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett. 282(2):137-145; 2009.
83. Read, T. A.; Fogarty, M. P.; Markant, S. L.; McLendon, R. E.; Wei, Z.; Ellison, D. W.; Febbo, P. G.; Wechsler- Reya, R. J. Identification of CD15 as a marker for tumorpropagating cells in a mouse model of medulloblastoma. Cancer Cell 15(2):135-147; 2009.
84. Rebetz, J.; Tian, D.; Persson, A.; Widegren, B.; Salford, L. G.; Englund, E.; Gisselsson, D.; Fan, X. Glial progenitor-like phenotype in low-grade glioma and enhanced CD133- expression and neuronal lineage differentiation potential in high-grade glioma. PLoS One 3(4):e1936; 2008.
85. Reynolds, B. A.; Rietze, R. L. Neural stem cells and neurospheres- reevaluating the relationship. Nat. Methods 2(5):333-336; 2005.
86. Reynolds, B. A.; Weiss, S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev. Biol. 175(1):1-13; 1996.
87. Reynolds, B. A.; Weiss, S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255(5052):1707-1710; 1992.
88. Ricci-Vitiani, L.; Lombardi, D. G.; Pilozzi, E.; Biffoni, M.; Todaro, M.; Peschle, C.; De Maria, R. Identification and expansion of human colon-cancer-initiating cells. Nature 445(7123):111-115; 2007.
89. Schatton, T.; Murphy, G. F.; Frank, N. Y.; Yamaura, K.; Waaga-Gasser, A. M.; Gasser, M.; Zhan, Q.; Jordan, S.; Duncan, L. M.; Weishaupt, C.; Fuhlbrigge, R. C.; Kupper, T. S.; Sayegh, M. H.; Frank, M. H. Identification of cells initiating human melanomas. Nature 451(7176):345-349; 2008.
90. Schmid, R. S.; Maness, P. F. L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth. Curr. Opin. Neurobiol. 18(3):245-250; 2008.
91. Schraivogel, D.; Weinmann, L.; Beier, D.; Tabatabai, G.; Eichner, A.; Zhu, J. Y.; Anton, M.; Sixt, M.; Weller, M.; Beier, C. P.; Meister, G. CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells. EMBO J. 30(20):4309-4322; 2011.
92. Schuurhuis, G. J.; Muijen, M. M.; Oberink, J. W.; de Boer, F.; Ossenkoppele, G. J.; Broxterman, H. J. Large populations of non-clonogenic early apoptotic CD34-positive cells are present in frozen-thawed peripheral blood stem cell transplants. Bone Marrow Transplant. 27(5):487-498; 2001.
93. Shen, Q.; Wang, Y.; Kokovay, E.; Lin, G.; Chuang, S. M.; Goderie, S. K.; Roysam, B.; Temple, S. Adult SVZ stem cells lie in a vascular niche: A quantitative analysis of niche cell-cell interactions. Cell Stem Cell 3(3):289-300; 2008.
94. Shi, L.; Zhang, J.; Pan, T.; Zhou, J.; Gong, W.; Liu, N.; Fu, Z.; You, Y. MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation. Brain Res. 1312:120-126; 2010.
95. Silber, J.; Jacobsen, A.; Ozawa, T.; Harinath, G.; Pedraza, A.; Sander, C.; Holland, E. C.; Huse, J. T. miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis. PLoS One 7(3):e33844; 2012.
96. Silber, J.; Lim, D. A.; Petritsch, C.; Persson, A. I.; Maunakea, A. K.; Yu, M.; Vandenberg, S. R.; Ginzinger, D. G.; James, C. D.; Costello, J. F.; Bergers, G.; Weiss, W. A.; Alvarez-Buylla, A.; Hodgson, J. G. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 6:14; 2008.
97. Singec, I.; Knoth, R.; Meyer, R. P.; Maciaczyk, J.; Volk, B.; Nikkhah, G.; Frotscher, M.; Snyder, E. Y. Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology. Nat. Methods 3(10):801-806; 2006.
98. Singh, S. K.; Clarke, I. D.; Hide, T.; Dirks, P. B. Cancer stem cells in nervous system tumors. Oncogene 23(43):7267-7273; 2004.
99. Singh, S. K.; Clarke, I. D.; Terasaki, M.; Bonn, V. E.; Hawkins, C.; Squire, J.; Dirks, P. B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63(18):5821-5828; 2003.
100. Singh, S. K.; Hawkins, C.; Clarke, I. D.; Squire, J. A.; Bayani, J.; Hide, T.; Henkelman, R. M.; Cusimano, M. D.; Dirks, P. B. Identification of human brain tumour initiating cells. Nature 432(7015):396-401; 2004.
101. Son, M. J.; Woolard, K.; Nam, D. H.; Lee, J.; Fine, H. A. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 4(5):440-452; 2009.
102. Srivastava, V. K.; Nalbantoglu, J. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype. Cytometry A 73(10):940-948; 2008.
103. Stupp, R.; Hegi, M. E.; Mason, W. P.; van den Bent, M. J.; Taphoorn, M. J.; Janzer, R. C.; Ludwin, S. K.; Allgeier, A.; Fisher, B.; Belanger, K.; Hau, P.; Brandes, A. A.; Gijtenbeek, J.; Marosi, C.; Vecht, C. J.; Mokhtari, K.; Wesseling, P.; Villa, S.; Eisenhauer, E.; Gorlia, T.; Weller, M.; Lacombe, D.; Cairncross, J. G.; Mirimanoff, R. O. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10(5):459-466; 2009.
104. Stupp, R.; Mason, W. P.; van den Bent, M. J.; Weller, M.; Fisher, B.; Taphoorn, M. J.; Belanger, K.; Brandes, A. A.; Marosi, C.; Bogdahn, U.; Curschmann, J.; Janzer, R. C.; Ludwin, S. K.; Gorlia, T.; Allgeier, A.; Lacombe, D.; Cairncross, J. G.; Eisenhauer, E.; Mirimanoff, R. O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352(10):987-996; 2005.
105. Su, Y.; Qiu, Q.; Zhang, X.; Jiang, Z.; Leng, Q.; Liu, Z.; Stass, S. A.; Jiang, F. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol. Biomarkers Prev. 19(2):327-337; 2010.
106. Szakacs, G.; Paterson, J. K.; Ludwig, J. A.; Booth-Genthe, C.; Gottesman, M. M. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 5(3):219-234; 2006.
107. Taylor, M. D.; Poppleton, H.; Fuller, C.; Su, X.; Liu, Y.; Jensen, P.; Magdaleno, S.; Dalton, J.; Calabrese, C.; Board, J.; Macdonald, T.; Rutka, J.; Guha, A.; Gajjar, A.; Curran, T.; Gilbertson, R. J. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8(4):323-335; 2005.
108. Tchoghandjian, A.; Baeza, N.; Colin, C.; Cayre, M.; Metellus, P.; Beclin, C.; Ouafik, L.; Figarella-Branger, D. A2B5 cells from human glioblastoma have cancer stem cell properties. Brain Pathol. 20(1):211-221; 2010.
109. Uchida, N.; Buck, D. W.; He, D.; Reitsma, M. J.; Masek, M.; Phan, T. V.; Tsukamoto, A. S.; Gage, F. H.; Weissman, I. L. Direct isolation of human central nervous system stem cells. Proc. Natl. Acad. Sci. USA 97(26):14720-14725; 2000.
110. Wan, F.; Zhang, S.; Xie, R.; Gao, B.; Campos, B.; Herold- Mende, C.; Lei, T. The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research. Brain Pathol. 20(5):877-889; 2010.
111. Wan, Y.; Fei, X. F.; Wang, Z. M.; Jiang, D. Y.; Chen, H. C.; Yang, J.; Shi, L.; Huang, Q. Expression of miR- 125b in the new, highly invasive glioma stem cell and progenitor cell line SU3. Chin. J. Cancer 31(4):207-214; 2012.
112. Wang, J.; Sakariassen, P. O.; Tsinkalovsky, O.; Immervoll, H.; Boe, S. O.; Svendsen, A.; Prestegarden, L.; Rosland, G.; Thorsen, F.; Stuhr, L.; Molven, A.; Bjerkvig, R.; Enger, P. O. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int. J. Cancer 122(4):761-768; 2008.
113. Wang, J.; Wang, C.; Meng, Q.; Li, S.; Sun, X.; Bo, Y.; Yao, W. Sirna targeting Notch-1 decreases glioma stem cell proliferation and tumor growth. Mol. Biol. Rep. 39(3):2497-2503; 2012.
114. Ward, R. J.; Lee, L.; Graham, K.; Satkunendran, T.; Yoshikawa, K.; Ling, E.; Harper, L.; Austin, R.; Nieuwenhuis, E.; Clarke, I. D.; Hui, C. C.; Dirks, P. B. Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma. Cancer Res. 69(11):4682-4690; 2009.
115. Webster, R. J.; Giles, K. M.; Price, K. J.; Zhang, P. M.; Mattick, J. S.; Leedman, P. J. Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J. Biol. Chem. 284(9):5731-5741; 2009.
116. Werbowetski-Ogilvie, T. E.; Morrison, L. C.; Fiebig- Comyn, A.; Bhatia, M. In vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation. Stem Cells 30(3):392-404; 2012.
117. Wognum, A. W.; Eaves, A. C.; Thomas, T. E. Identification and isolation of hematopoietic stem cells. Arch. Med. Res. 34(6):461-475; 2003.
118. Xia, C. L.; Du, Z. W.; Liu, Z. Y.; Huang, Q.; Chan, W. Y. A2B5 lineages of human astrocytic tumors and their recurrence. Int. J. Oncol. 23(2):353-361; 2003.
119. Xia, H.; Cheung, W. K.; Ng, S. S.; Jiang, X.; Jiang, S.; Sze, J.; Leung, G. K.; Lu, G.; Chan, D. T.; Bian, X. W.; Kung, H. F.; Poon, W. S.; Lin, M. C. Loss of brain-enriched miR- 124 microRNA enhances stem-like traits and invasiveness of glioma cells. J. Biol. Chem. 287(13):9962-9971; 2012.
120. Xie, Z. Brain tumor stem cells. Neurochem. Res. 34(12):2055-2066; 2009.
121. Yanagisawa, M. Stem cell glycolipids. Neurochem. Res. 36(9):1623-1635; 2011.
122. Yuan, X.; Curtin, J.; Xiong, Y.; Liu, G.; Waschsmann- Hogiu, S.; Farkas, D. L.; Black, K. L.; Yu, J. S. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23(58):9392-9400; 2004.
123. Zeppernick, F.; Ahmadi, R.; Campos, B.; Dictus, C.; Helmke, B. M.; Becker, N.; Lichter, P.; Unterberg, A.; Radlwimmer, B.; Herold-Mende, C. C. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin. Cancer Res. 14(1):123-129; 2008.
124. Zhang, Q. B.; Ji, X. Y.; Huang, Q.; Dong, J.; Zhu, Y. D.; Lan, Q. Differentiation profile of brain tumor stem cells: A comparative study with neural stem cells. Cell Res. 16(12):909-915; 2006.
125. Zhang, X. P.; Zheng, G.; Zou, L.; Liu, H. L.; Hou, L. H.; Zhou, P.; Yin, D. D.; Zheng, Q. J.; Liang, L.; Zhang, S. Z.; Feng, L.; Yao, L. B.; Yang, A. G.; Han, H.; Chen, J. Y. Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells. Mol. Cell. Biochem. 307(1-2):101-108; 2008.
126. Zheng, X.; Shen, G.; Yang, X.; Liu, W. Most C6 cells are cancer stem cells: Evidence from clonal and population analyses. Cancer Res. 67(8):3691-3697; 2007.